Journal of Medicinal Chemistry · 2014 · 38 citations · 121 references
MedicineMolecular BiologyOncologyChemotherapyDna RepairMolecular OncologyDna Damage SignalingDna Double-strand Break RepairDna Repair In CarcinogenesisDouble-strand Break RepairAnticancer ChemotherapyApe1-mediated RepairApurinic EndonucleasesApyrimidinic EndonucleasesDna Damage Response InhibitorsDna Damage Response TargetingDna Damage ResponsesScope
The apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1) is a multifunctional enzyme involved in DNA repair and activation of transcription factors through its redox function. The evolutionarily conserved C- and N-termini are involved in these functions independently. It is also reported that the activity of APE1/Ref-1 abruptly increases several-fold in various human cancers. The control over the outcomes of these two functions is emerging as a new strategy to combine enhanced DNA damage and chemotherapy in order to tackle the major hurdle of increased cancer cell growth and proliferation. Studies have targeted these two domains individually for the design and development of inhibitors for APE1/Ref-1. Here, we have made, for the first time, an attempt at a comparative analysis of APE1/Ref-1 inhibitors that target both DNA repair and redox activities simultaneously. We further discuss their scope and limitations with respect to the development of potential anticancer agents.
121
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li, Shideng Bao, Qiulian Wu et al. · Cancer Cell · 2009 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Redox activation of Fos‐Jun DNA binding activity is mediated by a DNA repair enzyme.
Steven Xanthoudakis, Graham G. Miao, F. Wang et al. · The EMBO Journal · 1992 · 927 citations · Full text